[1]
Vahedpour, T. , Nazari, M., Rezaee, E. and Tabatabai, S.A. 2021. Design, synthesis and biological evaluation of new 2,5-diaryl-1,3,4-oxadiazole derivatives as selective cyclooxygenase-2 inhibitors : Novel 2,5-diaryl-1,3,4-oxadiazole derivatives as selective cyclooxygenase-2 inhibitors. International Pharmacy Acta. 4, 1 (May 2021), 4e3:1–6. DOI:https://doi.org/10.22037/ipa.v4i1.34360.